Neoplasms Clinical Trial
Official title:
A Shared Care Approach for Seriously Ill Cancer Patients Between General Practice, Discharge Department and a Specialist Palliative Care Team
Background:
Approximately one third of all deaths in Denmark are caused by cancer. Both Danish and
international research shows that the majority of terminally ill cancer patients wish to die
at home. In Denmark only about 25% has this wish fulfilled. The General Practitioner (GP)
has traditionally had the full responsibility for the palliative care of terminally ill
cancer patients. In recent years changes have been made to the organisation of palliative
care: some hospitals have set up specialised palliative care teams and in some areas of
Denmark hospices have been established.
Recent research defines a problem when it comes to communication between the hospital and
general practice when the patient is being discharged. This is often done in a way that can
cause the patient to feel "left in limbo", especially if it is not completely clear to the
patient and his or her relatives who has the responsibility for the palliative care.
Objective:
1. To describe consequences for patients, relatives and health care professionals of three
different ways of organising palliative care
2. To collect data which describes patients who are candidates to a shared care approach
between general practice and a specialised palliative care team
3. To collect data which describes the palliative phase (place of death and palliative
care, admissions to hospital, involvement of GP and district nurse etc.)
4. To describe terminally ill cancer patients and their relatives expectations of the
health care system
270 terminally ill cancer patients will be invited to take part in the study. Data will be
collected by interview with patients and questionnaires for patients, relatives and involved
health care professionals.
The intervention in the study is of organisational character. The patients will be
randomised into two groups (groups B and C). A group of usual care patients will be included
primary to the intervention (group A). The groups are:
A. Usual discharge with regular discharge letter to the GP. The GP, together with the
community nurse, is responsible for the palliative care, including referral to a specialist
palliative care team, hospice, hospital, etc., if necessary
B. Discharge with referral to a specialist palliative care team. This is a patient-centred
shared care model in which the palliative team helps to organise the patient's treatment and
care
C. Discharge with extra effort put into improving the communication between the hospital and
the GP. The GP will receive a phone call from the doctor who is discharging the patient, a
detailed discharge letter, written information about the patient's type of cancer and acute
oncological symptoms, name and phone number of the community nurse and name and phone number
of a specialist in palliative medicine, who can be contacted for advice. This is a shared
care model, where focus is on supporting the health care professionals.
;
Allocation: Randomized, Intervention Model: Factorial Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03826043 -
THrombo-Embolic Event in Onco-hematology
|
N/A | |
Terminated |
NCT03166631 -
A Trial to Find the Safe Dose for BI 891065 Alone and in Combination With BI 754091 in Patients With Incurable Tumours or Tumours That Have Spread
|
Phase 1 | |
Completed |
NCT01938846 -
BI 860585 Dose Escalation Single Agent and in Combination With Exemestane or With Paclitaxel in Patients With Various Advanced and/or Metastatic Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06058312 -
Individual Food Preferences for the Mediterranean Diet in Cancer Patients
|
N/A | |
Completed |
NCT03308942 -
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
|
Phase 2 | |
Recruiting |
NCT06018311 -
Exercising Together for Hispanic Prostate Cancer Survivor-Caregiver Dyads
|
N/A | |
Withdrawn |
NCT05431439 -
Omics of Cancer: OncoGenomics
|
||
Completed |
NCT01343043 -
A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma
|
Phase 1 | |
Completed |
NCT01938638 -
Open Label Phase I Dose Escalation Study With BAY1143572 in Patients With Advanced Cancer
|
Phase 1 | |
Recruiting |
NCT05514444 -
Study of MK-4464 as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors (MK-4464-001)
|
Phase 1 | |
Recruiting |
NCT02292641 -
Beyond TME Origins
|
N/A | |
Terminated |
NCT00954512 -
Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)
|
Phase 1/Phase 2 | |
Recruiting |
NCT04958239 -
A Study to Test Different Doses of BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors)
|
Phase 1 | |
Recruiting |
NCT04627376 -
Multimodal Program for Cancer Related Cachexia Prevention
|
N/A | |
Completed |
NCT01222728 -
Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
|
||
Recruiting |
NCT06004440 -
Real World Registry for Use of the Ion Endoluminal System
|
||
Active, not recruiting |
NCT05636696 -
COMPANION: A Couple Intervention Targeting Cancer-related Fatigue
|
N/A | |
Not yet recruiting |
NCT06035549 -
Resilience in East Asian Immigrants for Advance Care Planning Discussions
|
N/A | |
Recruiting |
NCT06004466 -
Noninvasive Internal Jugular Venous Oximetry
|
||
Completed |
NCT03190811 -
Anti-PD-1 Alone or Combined With Autologous DC-CIK Cell Therapy in Advanced Solid Tumors
|
Phase 1/Phase 2 |